trial news

AGITG Trial News

Trial news: The AGITG currently has seven studies open to recruitment and ten studies in follow up.

The  table below details the trials that are currently accruing patients.

Recruited Target
ACTICCA-1- Gallbladder carcinoma 3 50
ASCOLT — Colorectal cancer 276 300
CONTROL NETs — NeuroEndocrine Tumour 69 72
INTEGRATE II –  Gastro-Oesophageal 28 350
NABNEC  — NeuroEndocrine Tumour 19 70
TOP GEAR — Stomach cancer 192 752
DYNAMIC-III 23 1,000


Trial Results Lay Summaries
(click on the links below):Recruitment figures to end March 2018.

ALaCaRT
ATTACHE
ATTAX-3
GAP
ICECREAM
INTEGRATE
TACTIC
TOP GEAR
CO.17
EORTC 62024
Advanced GIST